GT Medical Technologies, Inc., a company focused on improving the lives of patients with brain tumors, today announced a publication of prospective, multicenter Phase IV data from the ongoing ...
Atrial fibrillation is the most common form of heart rhythm disorder and is linked to serious complications, including stroke and heart failure. While earlier research pointed to a possible ...
CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...
Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population Adj PD-1 therapy did not improve ...
A large, multi-center study published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy ...
7don MSN
Adagio Medical (ADGM) announces successful results from US cardiac ablation feasibility study
Adagio Medical Holdings Inc. (NASDAQ:ADGM) is one of the best up and coming penny stocks to buy. On February 4, Adagio Medical Holdings announced the publication of results from its US Early ...
Effective Patient Triaging: Prospective clinical data demonstrated a significant reduction in recall rates for low-risk cases, decreasing from 7.6% to 5.7%, which minimizes nonessential follow-up ...
This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results